DDEL-07. A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of MTX110 for the treatment of children with newly diagnosed diffuse midline gliomas (DMGs)

Zacharoulis, S., Szalontay, L., CreveCoeur, T., Neira, J., Higgins, D., Englander, Z., Spinazzi, E., Sethi, C., Canoll, P., Garvin, J., Zylber, R., Damment, S., Zamoryakhin, D., Maddocks, A., Feldstein, N., & Bruce, J. (2022). DDEL-07. A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of MTX110 for the treatment of children with newly diagnosed diffuse midline gliomas (DMGs). Neuro-Oncology, 24(Supplement_1), i35–i35. https://doi.org/10.1093/neuonc/noac079.128
Authors:
Stergios Zacharoulis
Luca Szalontay
Travis S. CreveCoeur
Justin A. Neira
Dominique Higgins
Zachary Englander
Eleonora F. Spinazzi
Chankrit Sethi
Peter Canoll
James Garvin
Rebecca J. Zylber
Steve Damment
Dmitry Zamoryakhin
Alexis Maddocks
Neil A. Feldstein
Jeffrey Bruce
Affiliated Authors:
Stergios Zacharoulis
Luca Szalontay
Travis S. CreveCoeur
Justin A. Neira
Dominique Higgins
Zachary Englander
Eleonora F. Spinazzi
Chankrit Sethi
Peter Canoll
James Garvin
Rebecca J. Zylber
Alexis Maddocks
Neil A. Feldstein
Jeffrey Bruce
Publication Type:
Article
Unique ID:
10.1093/neuonc/noac079.128
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: